Requests President and Congress to take action to permit federal Medicaid funding for certain substance use disorder programs.
Impact
The implications of SCR57 could significantly change how states manage funding for substance use disorder programs. By advocating for the repeal of the IMD exclusion, the resolution aims to improve access to critical treatment options that may be limited by current federal regulations. If successful, this could alleviate some financial burdens on states that must cover the costs of services not reimbursed by Medicaid, potentially leading to expanded treatment availability for those in need. Additionally, the action would align federal healthcare provisions more closely with the realities of mental health treatment, acknowledging substance use disorders as significant health issues.
Summary
SCR57 is a Senate Concurrent Resolution from New Jersey that requests the President and Congress to take action to allow federal Medicaid funding for substance use disorder programs. It highlights the existing limitations within the Medicaid program, particularly the Institution for Mental Diseases (IMD) exclusion, which restricts federal reimbursement for most in-patient and out-patient rehabilitation services for individuals seeking treatment for substance use disorders. This bill exemplifies the ongoing challenges in accessing necessary healthcare for individuals battling these disorders, especially those aged 21 to 64 who are often affected by the exclusion of services offered in IMDs.
Contention
The primary contention surrounding SCR57 lies in the complexities involved in amending federal Medicaid provisions. Supporters argue that modifying the IMD exclusion could enhance service accessibility, while critics might contend that such changes would require careful consideration of funding allocations and the long-term implications for state budgets. The resolution suggests that by allowing more comprehensive federal funding for these services, states can offer better support for recovery programs—timely access to these treatments is often critical given the urgent nature of substance use disorders.
Urges U.S. President, Congress, and Department of Health and Human Services to ease patient limits applicable to private physicians prescribing buprenorphine as part of medication-assisted treatment for substance use disorders.
Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.
Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.
Requesting The Department Of Health To Restore Funding To Certain Substance Use Disorder Treatment Organizations That Provide Services For Residential, Outpatient, And Adult And Adolescent School-based Programs In Fiscal Years 2022-2023 And 2023-2024.
Requesting The Department Of Health To Restore Funding To Certain Substance Use Disorder Treatment Organizations That Provide Services For Residential, Outpatient, And Adult And Adolescent School-based Programs In Fiscal Years 2022-2023 And 2023-2024.
Establishes Office of Alcohol and Drug Use Disorders Policy to oversee, direct, and coordinate resources, funding, and data tracking concerning treatment of substance use disorders.
Establishes Office of Alcohol and Drug Use Disorders Policy to oversee, direct, and coordinate resources, funding, and data tracking concerning treatment of substance use disorders.
Establishes Office of Alcohol and Drug Use Disorders Policy to oversee, direct, and coordinate resources, funding, and data tracking concerning treatment of substance use disorders.